Identification of an m6A-Related lncRNA Signature for Predicting the Prognosis in Patients With Kidney Renal Clear Cell Carcinoma

被引:48
|
作者
Yu, JunJie [1 ]
Mao, WeiPu [1 ]
Sun, Si [1 ]
Hu, Qiang [1 ]
Wang, Can [1 ]
Xu, ZhiPeng [1 ]
Liu, RuiJi [1 ]
Chen, SaiSai [1 ]
Xu, Bin [2 ]
Chen, Ming [2 ,3 ]
机构
[1] Southeast Univ, Coll Med, Nanjing, Peoples R China
[2] Southeast Univ, Dept Urol, Affiliated Zhongda Hosp, Nanjing, Peoples R China
[3] Southeast Univ, Dept Urol, Affiliated Lishui Peoples Hosp, Nanjing, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 11卷
基金
中国国家自然科学基金;
关键词
prognostic signature; The Cancer Genome Atlas; long non-coding RNA; kidney renal clear cell carcinoma; M6A; PARTIAL NEPHRECTOMY; NONCODING RNAS; EXPRESSION; CANCER;
D O I
10.3389/fonc.2021.663263
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose This study aimed to construct an m6A-related long non-coding RNAs (lncRNAs) signature to accurately predict the prognosis of kidney clear cell carcinoma (KIRC) patients using data obtained from The Cancer Genome Atlas (TCGA) database. Methods The KIRC patient data were downloaded from TCGA database and m6A-related genes were obtained from published articles. Pearson correlation analysis was implemented to identify m6A-related lncRNAs. Univariate, Lasso, and multivariate Cox regression analyses were used to identifying prognostic risk-associated lncRNAs. Five lncRNAs were identified and used to construct a prognostic signature in training set. Kaplan-Meier curves and receiver operating characteristic (ROC) curves were applied to evaluate reliability and sensitivity of the signature in testing set and overall set, respectively. A prognostic nomogram was established to predict the probable 1-, 3-, and 5-year overall survival of KIRC patients quantitatively. GSEA was performed to explore the potential biological processes and cellular pathways. Besides, the lncRNA/miRNA/mRNA ceRNA network and PPI network were constructed based on weighted gene co-expression network analysis (WGCNA). Functional Enrichment Analysis was used to identify the biological functions of m6A-related lncRNAs. Results We constructed and verified an m6A-related lncRNAs prognostic signature of KIRC patients in TCGA database. We confirmed that the survival rates of KIRC patients with high-risk subgroup were significantly poorer than those with low-risk subgroup in the training set and testing set. ROC curves indicated that the prognostic signature had a reliable predictive capability in the training set (AUC = 0.802) and testing set (AUC = 0.725), respectively. Also, we established a prognostic nomogram with a high C-index and accomplished good prediction accuracy. The lncRNA/miRNA/mRNA ceRNA network and PPI network, as well as functional enrichment analysis provided us with new ways to search for potential biological functions. Conclusions We constructed an m6A-related lncRNAs prognostic signature which could accurately predict the prognosis of KIRC patients.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Construction of a Lactate-Related Prognostic Signature for Predicting Prognosis, Tumor Microenvironment, and Immune Response in Kidney Renal Clear Cell Carcinoma
    Sun, Zhuolun
    Tao, Wen
    Guo, Xudong
    Jing, Changying
    Zhang, Mingxiao
    Wang, Zhenqing
    Kong, Feng
    Suo, Ning
    Jiang, Shaobo
    Wang, Hanbo
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [32] Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma
    Lin, Hang
    Qu, Lingzhi
    Chen, Guanqiu
    Zhang, Chunfang
    Lu, Liqing
    Chen, Yongheng
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2023, 28 (01)
  • [33] A novel m6A-related prognostic signature for predicting the overall survival of hepatocellular carcinoma patients
    Xie, Shiyang
    Wang, Yaxuan
    Huang, Jin
    Li, Guang
    IET SYSTEMS BIOLOGY, 2022, 16 (01) : 1 - 17
  • [34] Identification of a Glucose Metabolism-related Signature for prediction of Clinical Prognosis in Clear Cell Renal Cell Carcinoma
    Wang, Sheng
    Zhang, Ling
    Yu, Zhihong
    Chai, Kequn
    Chen, Jiabin
    JOURNAL OF CANCER, 2020, 11 (17): : 4996 - 5006
  • [35] Identification of a 5-Gene Signature Predicting Progression and Prognosis of Clear Cell Renal Cell Carcinoma
    Pan, Qiufeng
    Wang, Longwang
    Zhang, Hao
    Liang, Chaoqi
    Li, Bing
    MEDICAL SCIENCE MONITOR, 2019, 25 : 4401 - 4413
  • [36] A novel oxidative-stress related lncRNA signature predicts the prognosis of clear cell renal cell carcinoma
    Zhang, Yu
    Zhou, Guozhong
    Shi, Wei
    Shi, Weili
    Hu, Meijun
    Kong, Defu
    Long, Rong
    Chen, Nan
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma
    Weng, Chengyin
    Wang, Lina
    Liu, Guolong
    Guan, Mingmei
    Lu, Lin
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [38] Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma
    Liao, Wanying
    Long, Junyu
    Li, Yiran
    Xie, Fucun
    Xun, Ziyu
    Wang, Yanyu
    Yang, Xu
    Wang, Yunchao
    Zhou, Kang
    Sang, Xinting
    Zhao, Haitao
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
  • [39] Prognosis Signature of Cuprotosis-Related lncRNAs Associated with Kidney Renal Clear Cell Carcinoma
    Gao, Yiren
    Jia, Zhen
    GENETICS RESEARCH, 2022, 2022
  • [40] An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma
    Li, Jiaying
    Gui, Chengpeng
    Yao, Haohua
    Luo, Chenggong
    Song, Hongde
    Lin, Haishan
    Xu, Quanhui
    Chen, Xu
    Huang, Yong
    Luo, Junhang
    Chen, Wei
    FRONTIERS IN GENETICS, 2022, 13